Understanding a Potential Role for the NLRP3 Inflammasome in Placenta‐Mediated Pregnancy Complications
American Journal of Reproductive Immunology · 2025-04 · 93 (4)
DOI: 10.1111/aji.70077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 22.04.2025. Verfasst von Chloe G Moss und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Placenta, Pregnancy Complications. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tommy's Baby Charity.
Abstract (Originalsprache)
Stillbirth affects approximately 2 million pregnancies annually and is closely linked to placental dysfunction, which may also present clinically as foetal growth restriction (FGR) or pre‐eclampsia (PE). Placental dysfunction can arise from a range of insults, including the inflammatory conditions villitis of unknown aetiology (VUE) and chronic histiocytic intervillositis (CHI). Despite ample research regarding the pathophysiology of placental dysfunction, the literature surrounding placental inflammation is more limited, with no currently established treatments. In the absence of infection, placental inflammation is hypothesised to be stimulated by damage‐associated molecular patterns (DAMPs), known as sterile inflammation. The NLRP3 inflammasome, a protein scaffold that unites within the cytosol of cells, is a proposed contributor. The NLRP3 inflammasome is dysregulated in numerous diseases and has shown evidence of activation through the sterile inflammatory pathway via DAMPs. Studies have demonstrated the upregulation of the NLRP3 inflammasome and its components in placentally‐mediated pregnancy pathologies. However, the link between placental dysfunction seen in these disorders and the NLRP3 inflammasome is not yet firmly established. This manuscript aims to review the evidence regarding placental inflammation seen with placental dysfunction, discuss its association with the NLRP3 inflammasome, and identify potential therapeutic interventions for this pathological inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, University of Manchester, Manchester, UK.
- Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
- Department of Obstetrics and Gynaecology, Olson Center for Women's Health, University of Nebraska Medical Centre, Omaha, USA.
- Division of Pharmacy and Optometry, University of Manchester, Manchester, UK.
ORCID-Profile: Chloe G Moss
Förderung
- Tommy's Baby Charity
Zitieren
APA
Moss, C. G., Dilworth, M. R., Harris, L. K., Freeman, S., & Heazell, A. E. P. (2025). Understanding a Potential Role for the NLRP3 Inflammasome in Placenta‐Mediated Pregnancy Complications. American Journal of Reproductive Immunology, 93(4). https://doi.org/10.1111/aji.70077
Vancouver
Moss CG, Dilworth MR, Harris LK, Freeman S, Heazell AEP. Understanding a Potential Role for the NLRP3 Inflammasome in Placenta‐Mediated Pregnancy Complications. American Journal of Reproductive Immunology. 2025;93(4). doi:10.1111/aji.70077
BibTeX
@article{Moss2025,
author = {Moss, Chloe G and Dilworth, Mark R and Harris, Lynda K and Freeman, Sally and Heazell, Alexander E P},
title = {Understanding a Potential Role for the NLRP3 Inflammasome in Placenta‐Mediated Pregnancy Complications},
journal = {American Journal of Reproductive Immunology},
year = {2025},
volume = {93},
number = {4},
doi = {10.1111/aji.70077}
}
EUVIMED